⚠ COVID-19 INFORMATION: Vaccine Information, Other Resources 

Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States

Official Title: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States

To describe the pharmacokinetic (PK) properties and safety of remdesivir (GS-5734TM) (RDV) administered to pregnant and non- pregnant women with COVID-19.

NCT04582266
Chadwick, Ellen G., MD
Interventional
Yes

Contact Information:

Lela Lartey

Nurse Coordinator Research

312.227.8266